SCHEMBL15020155

SCHEMBL15020155

O=C(O)c1cccc(C2CCC2)n1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.55
TDP1 Q9NUW8 2/20 0.55
ALOX15 P16050 1/20 0.55
TSHR P16473 1/20 0.55
ACMSD Q8TDX5 1/20 0.55
CNR2 P34972 7/20 0.55
GNE Q9Y223 1/20 0.47
KMO O15229 2/20 0.46
HCAR2 Q8TDS4 1/20 0.44
GLA P06280 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HIF1A Q16665 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
POLB P06746 1/20 0.41
ECE1 P42892 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14151725 0.96 CNR2 (0.58) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL11908195 0.95 CNR2 (0.61) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL15019902 0.93 KDM4E (0.59) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL30903051 0.93 KDM4E (0.59) KDM4ETDP1ALOX15TSHRACMSD
Lithium SCHEMBL29514614 0.91 KDM4E (0.57) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL14152086 0.85 CNR2 (0.60) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL9943901 0.82 CNR2 (0.49) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL412605 0.82 CNR2 (0.49) KDM4ETDP1ALOX15TSHRACMSD
Hydrochloric Acid SCHEMBL4291003 0.81 CNR2 (0.48) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL17489066 0.80 KDM4E (0.48) KDM4ETDP1ALOX15TSHRACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114378482-B Soldering flux and soldering paste 千住金属工业株式会社 2023-05-30 CN disclosed
CN-114378482-A Flux and solder paste 千住金属工业株式会社 2022-04-22 CN disclosed
US-20190184518-A1 ABRASIVE GRAINS, MANUFACTURING METHOD THEREFOR, POLISHING SLURRY CONTAINING SAID ABRASIVE GRAINS, AND POLISHING METHOD USING SAID POLISHING SLURRY BAIKOWSKI JAPAN CO., LTD. (JP) 2019-06-20 US disclosed
EP-3492546-A1 ABRASIVE GRAINS, MANUFACTURING METHOD THEREFOR, POLISHING SLURRY CONTAINING SAID ABRASIVE GRAINS, AND POLISHING METHOD USING SAID POLISHING SLURRY Baikowski Japan Co., Ltd. (JP) 2019-06-05 EP disclosed
CN-109601005-A Abrasive grain, method for producing same, polishing slurry containing abrasive grain, and polishing method using polishing slurry 日本百考基股份有限公司 2019-04-09 CN disclosed
CN-109530957-A Grafting material 丰田自动车株式会社 2019-03-29 CN disclosed
US-20190084093-A1 BONDING MATERIAL TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2019-03-21 US disclosed
EP-2791130-B1 PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS BOEHRINGER INGELHEIM INT (DE) 2016-03-16 EP disclosed
US-8883789-B2 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-11 US disclosed
US-8883789-B2 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-11 US disclosed
US-8883789-B2 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-11 US disclosed
EP-2791130-A1 PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS Boehringer Ingelheim International GmbH (DE) 2014-10-22 EP disclosed
WO-2013087805-A1 PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 WO disclosed
US-20130158042-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed
US-20130158042-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed
US-20130158042-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158042-A1 NOVEL COMPOUNDS GRM5, GRIK5, GRM1 KDM4E 1242/4885TDP1 1178/4885ALOX15 2751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.